Vigilant Biosciences Announces Commencement of FDA Studies for OncAlert® Cancer Test
FORT LAUDERDALE, Fla., May 10, 2017 /PRNewswire/ — Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of oral/oropharyngeal

